bpc 157 hims & Hers shares are trading higher after an FDA advisory panel recommended adding BPC-157 to the 503A compounding list, potentially widening access through licensed pharmacies BPC-157 PURE Immediate Release –

BPC 157 PURE Immediate Release Heart + Sol BPC 157 (Body Protection Compound 157) Limitless Wellness Lab HIMS FDA PANEL VOTES 'YES' ON BPC 157 THE 8 PCAC PANELIST MEMBERS WHO VOTED YES: 1. Asare Christian 2. David Pope 3. Gabriel Alizaidy 4. Haleem Mohammed 5. Joshua Starbuck 6. Kris Wusterhausen 7. Melissa Loseke 8. Bobby Harshbarger HIMS jumps more than 7% after an FDA panel recommends adding BPC 157 to the 503A compounding list potentially opening a new peptide category. The opportunity fits Hims existing telehealth, compounding and customer

SKU: 40363207221 · From www.djecji-vrtic-kucica.hr